{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:25:19Z","timestamp":1760016319316},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00687116","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:54:10Z","timestamp":1101718450000},"page":"S99-S102","source":"Crossref","is-referenced-by-count":29,"title":["Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system"],"prefix":"10.1007","volume":"31","author":[{"given":"Yasuaki","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokiko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choichiro","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1838","volume":"9","author":"Y Arai","year":"1982","unstructured":"Arai Y, Kamimura N, Suyama K (1982) A method for subcutaneously retaining a catheter connected to a new silicone reservoir in intra-arterial infusion chemotherapy. Jpn J Cancer Chemother 9: 1838","journal-title":"Jpn J Cancer Chemother"},{"key":"CR2","first-page":"102","volume":"7","author":"Y Arai","year":"1988","unstructured":"Arai Y, Kido C, Endo T, Miyake Y, Ariyoshi Y, Fukushima M (1988) Hepatic arterial infusion (HAI) chemotherapy for liver metastasis from colon, gastric and breast cancer (ca). Proc Am Soc Clin Oncol 7:102","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR3","first-page":"113","volume":"9","author":"Y Arai","year":"1990","unstructured":"Arai Y, Endo T, Miyake Y, Kido C, Ariyoshi Y (1990) A phase I trial of 5 hours hepatic arterial infusion (HAI) of high dose 5FU in weekly schedule for liver metastases from colorectal cancer (LMCRC). Proc Am Soc Clin Oncol 9:113","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR4","first-page":"114","volume":"9","author":"Y Arai","year":"1990","unstructured":"Arai Y, Endo T, Miyake Y, Sakamoto K, Tagaya T, Kido C (1990) A study of technical problems in hepatic arterial infusion chemotherapy using percutaneous approach. Jpn J Med Imaging 9:114","journal-title":"Jpn J Med Imaging"},{"key":"CR5","first-page":"142","volume":"10","author":"Y Arai","year":"1991","unstructured":"Arai Y, Sone Y, Tohyama N, Kido C, Ariyoshi Y (1991) A phase II study of 5 hours hepatic arterial infusion (HAI) of high dose 5FU in weekly schedule for liver metastases from colorectal cancer (LMCRC). Proc Am Soc Clin Oncol 10:142","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1097-0142(19800301)45:5<866::AID-CNCR2820450507>3.0.CO;2-3","volume":"45","author":"H Buchwald","year":"1980","unstructured":"Buchwald H, Grage TB, Vassilopoulus PP, Rohde TD, Varco RL, Blackshear PJ (1980) Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45:866","journal-title":"Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","volume":"206","author":"AE Chang","year":"1987","unstructured":"Chang AE, Schneider PO, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapyin the treatment of colorectal liver metastases. Ann Surg 206:685","journal-title":"Ann Surg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9343(82)90774-4","volume":"73","author":"J Gyves","year":"1982","unstructured":"Gyves J, Ensminger W, Niederhuber J, Liepman M, Cozzi E, Doan K, Dakhil S, Wheeler R (1982) Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 73:841","journal-title":"Am J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","volume":"7","author":"DC Hohn","year":"1989","unstructured":"Hohn DC, Stagg RJ, Friedman MA, Hannigan JR Jr. Rayner A, Ignoffo RJ, Acord P, Lewis BJ (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 7:1646","journal-title":"J Clin Oncol"},{"key":"CR10","first-page":"98","volume":"8","author":"A Katz","year":"1989","unstructured":"Katz A, Gansl R, Simon S, Gama-Rodrigues JJ, Waitzberg D, Breseiani C, Pinotti HV (1989) Phase II trial of VP-16 (V), Adriamycin (A) and cisplatinum (C) in patients (PTS) with advanced gastric cancer (AGC). Proc Am Soc Clin Oncol 8:98","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","volume":"107","author":"N Kemeny","year":"1987","unstructured":"Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107:459","journal-title":"Ann Intern Med"},{"key":"CR12","first-page":"103","volume":"9","author":"A Lerner","year":"1990","unstructured":"Lerner A, Steele GD, Mayer RJ (1990) Etoposide, doxorubicin, cisplatin (EAP) chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. Proc Am Soc Clin Oncol 9:103","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1097-0142(197907)44:1<42::AID-CNCR2820440108>3.0.CO;2-X","volume":"44","author":"JS MacDonald","year":"1979","unstructured":"MacDonald JS, Woolley PV, Smythe T, Ueno W, Hoth D, Schein PS (1979) 5-Fluorouracil, Adriamycin and mitomycin C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer 44:42","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1200\/JCO.1986.4.7.1053","volume":"4","author":"CG Moertel","year":"1986","unstructured":"Moertel CG, Rubin J, O'Connell MJ, Schutt AJ, Wieand HS (1986) A phase II study of combined 5-fluorouracil, doxorubicin and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 4:1053","journal-title":"J Clin Oncol"},{"key":"CR15","first-page":"98","volume":"8","author":"MJ O'Connell","year":"1989","unstructured":"O'Connell MJ, Mailliard J, Martin J, Fitzgibbons R, Nagorney D, Wieand H, Tschetter L, Krook J (1989) A controlled trial of regional intra-arterial FUDR versus systemic 5FU for the treatment of metastatic colorectal cancer confined to the liver. Proc Am Soc Clin Oncol 8:98","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR16","first-page":"322","volume-title":"Cancer chemotherapy vol 17","author":"M Ogawa","year":"1985","unstructured":"Ogawa M, Taguchi T (1985) 18 upper gastrointestinal tumors. In: Cancer chemotherapy vol 17. Excerpta Medica, Amsterdam, p 322"},{"key":"CR17","first-page":"241","volume-title":"Cancer chemotherapy and biological response modifiers, vol 10","author":"M Ogawa","year":"1988","unstructured":"Ogawa M, Taguchi T (1988) 17 upper gastrointestinal tumors. In: Cancer chemotherapy and biological response modifiers, vol 10. Excerpta Medica, Amsterdam, p 241"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649","journal-title":"Am J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1989.7.9.1310","volume":"7","author":"P Preusser","year":"1989","unstructured":"Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer H-J, Buente H (1989) Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7:1310","journal-title":"J Clin Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-0142(19810115)47:2<402::AID-CNCR2820470231>3.0.CO;2-B","volume":"47","author":"ML Reed","year":"1981","unstructured":"Reed ML, Vaitkevicius VK, Al-Sarraf M, Vaughn CB, Singhakowinta A, Sexon-Porte M, Izbicki R, Baker L, Straatsma GW (1981) The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer 47:402","journal-title":"Cancer"},{"key":"CR21","first-page":"108","volume":"8","author":"T Taguchi","year":"1989","unstructured":"Taguchi T (1989) Combination chemotherapy with etoposide (E), Adriamycin (A) and cisplatin (P) (EAP) for advanced gastric cancer. Proc Am Soc Clin Oncol 8:108","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF00257302","volume":"15","author":"DJT Wagener","year":"1985","unstructured":"Wagener DJT, Yap SH, Wobbes T, Burghouts JTM Dam FE van, Hillen HFP, Hoogendoorn GJ, Scheerder H, Vegt SGL van der (1985) Phase II trial of 5-fluorouracil, Adriamycin and cisplatin (FAP) in advanced gastric cancer. Cancer Chemother Pharmacol 15: 86","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR23","first-page":"455","volume":"22","author":"P Woolley","year":"1981","unstructured":"Woolley P, Smith F, Estevez R, Gisselbrecht C, Alvarez C, Boiron M, Machado C, Lagarde C, Schein P (1981) A phase II trial of 5-FU, Adriamycin and cisplatin (FAP) in advanced gastric cancer. Proc Am Assoc Cancer Res\/Am Soc Clin Oncol 22:455","journal-title":"Proc Am Assoc Cancer Res\/Am Soc Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00687116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00687116\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00687116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:11:14Z","timestamp":1554459074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00687116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00687116"],"URL":"https:\/\/doi.org\/10.1007\/bf00687116","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}